Salvianolic Acid C Inhibits the Epithelial-Mesenchymal Transition and Ameliorates Renal Tubulointerstitial Fibrosis
Frontiers in Bioscience-Landmark · 27.06.2023 · 28 (6)
DOI: 10.31083/j.fbl2806121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 27.06.2023. Verfasst von Ming Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China. Hauptthemen laut MEDLINE: Kidney Diseases, Ureteral Obstruction. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai, The Three Year Action Plan Project of Shanghai Accelerating Development of Traditional Chinese Medicine, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Salvianolic acid C (SAC) is a natural compound derived from Salvia miltiorrhiza that can protect against renal diseases. The aims of this work were to explore the effect of SAC on kidney tubulointerstitial fibrosis and study the associated mechanism.
Methods
Models for unilateral ureteral obstruction (UUO) and aristolochic acid I (AAI) were established in mice to study renal tubulointerstitial fibrosis. Rat kidney fibroblasts (NRK-49F) and human kidney epithelial cells (HK2) were used as cellular models to evaluate the effects of SAC on kidney fibrosis.
Results
Treatment with SAC for two weeks reduced the level of renal tubulointerstitial fibrosis in UUO- and AAI-induced fibrotic kidneys, as demonstrated by Masson’s staining and Western blot. SAC inhibited extracellular matrix protein expression in NRK-49F cells and TGF-β-stimulated HK2 cells in dose-dependent fashion. Moreover, SAC inhibited the expression of epithelial-mesenchymal transition (EMT) factors in animal and cellular models of kidney fibrosis, as well as the EMT-related transcription factor snail. Furthermore, SAC inhibited the fibrosis-related signaling pathway Smad3 in the fibrotic kidneys of two mouse models and in renal cells.
Conclusions
We conclude that SAC inhibits EMT and ameliorates tubulointerstitial fibrosis through involvement of the signaling pathway for transforming growth factor-β (TGF-β)/Smad.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China.
- TCM Institute of Kidney Disease of Shanghai University of Traditional Chinese Medicine, 201203 Shanghai, China.
- Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, 201203 Shanghai, China.
Förderung
- Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai
- The Three Year Action Plan Project of Shanghai Accelerating Development of Traditional Chinese Medicine
- National Natural Science Foundation of China
- Scientific Research Foundation of Shanghai Municipal Commission of Health and Family Planning
- 2021 Research Project of Blood Purification Center Branch of Chinese Hospital Association
Zitieren
APA
Wu, M., Lin, J., Huang, D., Ye, C., & Chen, D. (2023). Salvianolic Acid C Inhibits the Epithelial-Mesenchymal Transition and Ameliorates Renal Tubulointerstitial Fibrosis. Frontiers in Bioscience-Landmark, 28(6). https://doi.org/10.31083/j.fbl2806121
Vancouver
Wu M, Lin J, Huang D, Ye C, Chen D. Salvianolic Acid C Inhibits the Epithelial-Mesenchymal Transition and Ameliorates Renal Tubulointerstitial Fibrosis. Frontiers in Bioscience-Landmark. 2023;28(6). doi:10.31083/j.fbl2806121
BibTeX
@article{Wu2023,
author = {Wu, Ming and Lin, Junyan and Huang, Di and Ye, Chaoyang and Chen, Dongping},
title = {Salvianolic Acid C Inhibits the Epithelial-Mesenchymal Transition and Ameliorates Renal Tubulointerstitial Fibrosis},
journal = {Frontiers in Bioscience-Landmark},
year = {2023},
volume = {28},
number = {6},
doi = {10.31083/j.fbl2806121}
}
EUVIMED